Small molecule inhibitors target multiple neuropathological signaling to exert novel neuroprotection in intracranial aneurysms

• Үндсэн зохиолчид: Acharya Balkrishna (Зохиогч), Shalini Mishra (Зохиогч), Maneesha Rana (Зохиогч), Satyendra Kumar Rajput (Зохиогч), Suhrud Pathak (Зохиогч), Keyi Liu (Зохиогч), Muralikrishnan Dhanasekaran (Зохиогч), Vedpriya Arya (Зохиогч), Shalini Singh (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Intracranial aneurysms (IAs) represent a critical health concern due to their potential to rupture, leading to severe morbidity and mortality. Small molecule inhibitors (SMIs) have emerged as promising therapeutic candidates for managing IA progression and rupture risk. The current landscape of SMIs...